 pilot studi sandostatin therapi refractori hiv-associ diarrhea seventeen aid patient prospect open-label dose-find studi octreotid sandostatin therapi refractori diarrhea nonevalu due progress aid symptomatolog lack confirm hiv infect evalu patient microgram microgram microgram thrice daili dose sixth patient moder reduct stool volum microgram thrice relev criteria respons discontinu therapi diarrhea patient day reiniti octreotid patient treatment patient concurr cryptosporidi infect treatment drug mild symptomatolog patient long-term treatment stabl dose effect treat patient period month moder respond year patient dose increas symptom year treatment sever nausea inject dose cessat patient partial control diarrhea month dose increas data octreotid use therapeut valu hiv-associ diarrhea studi